Menopausal Hormone Therapy And Left Ventricular Function

Part of paid clinical trials in Rochester, Minnesota.

Sponsor
Mayo Clinic
Study ID
NCT07242391
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
FEMALE
Age
45 Years - 60 Years
Healthy Volunteers
Not accepted

Interventions

  • Menopausal Hormone Therapy — DRUG
    Taken in accordance with standard clinical practice, administered for a minimum duration of eight weeks.

Study Details

The purpose of this study is to compare left ventricular stroke volume and heart rate responses to bursts of SNA between PMF using, and not using, MHT.

Key Dates

Start date
Jul 31, 2026
Status verified
Apr 2026
Primary completion
Dec 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
50 participants (estimated)

Arms

  • Arm: Post-menopausal females using menopausal hormone therapy
    Post menopausal females taking a clinically prescribed menopausal hormone therapy (i.e. pill, patch, etc.)
  • Arm: Post-menopausal females not using menopausal hormone therapy

Primary Outcome Measure

Left ventricular stroke volume [ Time Frame: Baseline ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo Clinic in RochesterRochesterMinnesota55905
Joshua Bock, PhD
[email protected]
(507) 422-0768
Joshua Bock, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Rochester, MN

By condition
Menopause
By specialty
Women's healthFertility
By research site
Mayo Clinic in Rochester· Rochester, MN

Related Studies